Colossal Biosciences, a genetic engineering company focused on de-extincting past species, has announced $150 million in Series B funding, which it plans to use for bringing back the iconic dodo.
The resurrection of several extinct species is predicted to occur within the next five years. One company aiming to make that a reality is Texas-based startup Colossal Biosciences, founded in 2021 by some of the world’s leading experts in genomics. In May 2022, it appeared in the World Economic Forum’s list of Technology Pioneers and it won Genomics Innovation of the Year at the BioTech Breakthrough Awards.
Comments are closed.